GOLDSTEIN DOV A MD bought BIOA
February 1, 2026 · Form 4 insider transaction
GOLDSTEIN DOV A MD bought 3,541 shares of BioAge Labs, Inc. at $4.38 per share, a transaction worth $15.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,541
Price
$4.38
Total value
$15.5K
InsiderGOLDSTEIN DOV A MD
RoleOfficer, Director
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 1, 2026
Filing dateFebruary 3, 2026
Shares owned after29,491
OwnershipDirect
10b5-1 planNo
AmendedNo